logo-loader
NASDAQ:IOVA

Iovance Biotherapeutics

Market:
NASDAQ
Market Cap:
$5.33 billion
Price
36.15 USD
Change
1.40%
52 weeks high
41.49
52 weeks low
17.67

In brief

IOVANCE Biotherapeutics is focused on the development and commercialization of autologous cellular immunotherapies optimizing personalized, tumor-directed Tumor Infiltrating Lymphocytes (TIL).